canertinib has been researched along with Smallpox in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Challberg, MD; Fauci, AS | 1 |
| Damon, IK; Kim, M; Kim, SK; Morehead, TJ; Reche, PA; Reinherz, EL; Welsh, RM; Yang, H | 1 |
1 review(s) available for canertinib and Smallpox
| Article | Year |
|---|---|
Host-based antipoxvirus therapeutic strategies: turning the tables.
Topics: Biological Warfare; Genes, erbB-1; Humans; Morpholines; Protein-Tyrosine Kinases; Signal Transduction; Smallpox; Variola virus; Virus Activation | 2005 |
1 other study(ies) available for canertinib and Smallpox
| Article | Year |
|---|---|
Antiviral chemotherapy facilitates control of poxvirus infections through inhibition of cellular signal transduction.
Topics: Animals; Chlorocebus aethiops; DNA; ErbB Receptors; Growth Substances; HeLa Cells; Humans; Male; Mice; Morpholines; Pneumonia; Protein Transport; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-cbl; Quinazolines; Signal Transduction; Smallpox; T-Lymphocytes; Ubiquitin-Protein Ligases; Vaccinia; Vaccinia virus; Variola virus; Vero Cells; Viral Proteins | 2005 |